Stephen M. Moerlein

3.6k total citations
91 papers, 2.7k citations indexed

About

Stephen M. Moerlein is a scholar working on Radiology, Nuclear Medicine and Imaging, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Stephen M. Moerlein has authored 91 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Radiology, Nuclear Medicine and Imaging, 29 papers in Cellular and Molecular Neuroscience and 23 papers in Neurology. Recurrent topics in Stephen M. Moerlein's work include Radiopharmaceutical Chemistry and Applications (29 papers), Medical Imaging Techniques and Applications (27 papers) and Neurological disorders and treatments (19 papers). Stephen M. Moerlein is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (29 papers), Medical Imaging Techniques and Applications (27 papers) and Neurological disorders and treatments (19 papers). Stephen M. Moerlein collaborates with scholars based in United States, Germany and Ireland. Stephen M. Moerlein's co-authors include Joel S. Perlmutter, Michael J. Welch, Tom O. Videen, Lori McGee‐Minnich, G. Stöcklin, Brad A. Racette, Abraham Z. Snyder, Mark A. Mintun, Yvette I. Sheline and Kevin J. Black and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Neuroscience and Journal of the American College of Cardiology.

In The Last Decade

Stephen M. Moerlein

89 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen M. Moerlein United States	29	800	744	679	396	262	91	2.7k
Jörgen Bergman Finland	38	1.0k 1.3×	1.0k 1.4×	1.5k 2.1×	556 1.4×	130 0.5×	79	4.3k
Peter Bjurling Sweden	27	675 0.8×	456 0.6×	528 0.8×	550 1.4×	65 0.2×	63	2.1k
Luc Zimmer France	39	1.7k 2.1×	549 0.7×	459 0.7×	1.2k 3.1×	92 0.4×	173	4.5k
Richard Hargreaves United States	46	2.0k 2.5×	642 0.9×	234 0.3×	1.9k 4.9×	153 0.6×	152	6.8k
Hitoshi Shinotoh Japan	31	1.0k 1.3×	397 0.5×	1.4k 2.1×	490 1.2×	242 0.9×	109	3.4k
Mei‐Ping Kung United States	37	1.4k 1.8×	1.2k 1.6×	577 0.8×	1.1k 2.7×	25 0.1×	96	3.9k
Wolfgang Wadsak Austria	44	891 1.1×	2.0k 2.6×	239 0.4×	908 2.3×	38 0.1×	264	5.9k
E.S. Garnett Canada	33	962 1.2×	1.1k 1.5×	1.0k 1.5×	345 0.9×	21 0.1×	102	4.1k
Swen Hesse Germany	32	711 0.9×	505 0.7×	577 0.8×	454 1.1×	81 0.3×	134	3.1k
Sang Eun Kim South Korea	36	727 0.9×	943 1.3×	686 1.0×	510 1.3×	17 0.1×	162	3.4k

Countries citing papers authored by Stephen M. Moerlein

Since Specialization

Citations

This map shows the geographic impact of Stephen M. Moerlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen M. Moerlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen M. Moerlein more than expected).

Fields of papers citing papers by Stephen M. Moerlein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen M. Moerlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen M. Moerlein. The network helps show where Stephen M. Moerlein may publish in the future.

Co-authorship network of co-authors of Stephen M. Moerlein

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen M. Moerlein. A scholar is included among the top collaborators of Stephen M. Moerlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen M. Moerlein. Stephen M. Moerlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Criswell, Susan R., Susan Searles Nielsen, Mark N. Warden, et al.. (2020). [11C]dihydrotetrabenazine Positron Emission Tomography in Manganese-Exposed Workers. Journal of Occupational and Environmental Medicine. 62(10). 788–794. 4 indexed citations

Tian, Linlin, Yuanxuan Xia, Hubert Flores, et al.. (2015). Neuroimaging Analysis of the Dopamine Basis for Apathetic Behaviors in an MPTP-Lesioned Primate Model. PLoS ONE. 10(7). e0132064–e0132064. 22 indexed citations

Yue, Xuyi, et al.. (2015). Automated production of [ 18 F]VAT suitable for clinical PET study of vesicular acetylcholine transporter. Applied Radiation and Isotopes. 107. 40–46. 16 indexed citations

Eisenstein, Sarah A., Jo Ann V. Antenor‐Dorsey, Leonard Green, et al.. (2015). Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity. PLoS ONE. 10(7). e0133621–e0133621. 48 indexed citations

Eisenstein, Sarah A., Marilyn L. Piccirillo, Jo Ann V. Antenor‐Dorsey, et al.. (2012). Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N‐methyl)benperidol using PET. Synapse. 66(9). 770–780. 29 indexed citations

Criswell, Susan R., Joel S. Perlmutter, Tom O. Videen, et al.. (2011). Reduced uptake of [ ¹⁸ F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology. 76(15). 1296–1301. 61 indexed citations

Karimi, Morvarid, Stephen M. Moerlein, Tom O. Videen, et al.. (2010). Decreased striatal dopamine receptor binding in primary focal dystonia: A D2 or D3 defect?. Movement Disorders. 26(1). 100–106. 38 indexed citations

Racette, Brad A., Jo Ann V. Antenor, Lori McGee‐Minnich, et al.. (2006). [¹⁸F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 141B(3). 245–249. 11 indexed citations

Tabbal, Samer D., Jonathan W. Mink, Jo Ann V. Antenor, et al.. (2006). 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine. Neuroscience. 141(3). 1281–1287. 54 indexed citations

10.

Racette, Brad A., Jo Ann V. Antenor, Lori McGee‐Minnich, et al.. (2005). [¹⁸F]FDOPA PET and clinical features in parkinsonism due to manganism. Movement Disorders. 20(4). 492–496. 71 indexed citations

11.

Mintun, Mark A., Yvette I. Sheline, Stephen M. Moerlein, et al.. (2003). Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography. Biological Psychiatry. 55(3). 217–224. 121 indexed citations

12.

Perlmutter, Joel S., Mikula K. Stambuk, Joanne Markham, et al.. (1997). Decreased [¹⁸F]Spiperone Binding in Putamen in Idiopathic Focal Dystonia. Journal of Neuroscience. 17(2). 843–850. 165 indexed citations

13.

Moerlein, Stephen M., Joel S. Perlmutter, Joanne Markham, & Michael J. Welch. (1997). In Vivo Kinetics of [18F](N-Methyl)Benperidol: A Novel PET Tracer for Assessment of Dopaminergic D2-Like Receptor Binding. Journal of Cerebral Blood Flow & Metabolism. 17(8). 833–845. 30 indexed citations

14.

Moerlein, Stephen M., Joel S. Perlmutter, M. J. Welch, & Marcus E. Raichle. (1994). First-pass extraction fraction of iodine-123 labeled perfusion tracers in living primate brain. Nuclear Medicine and Biology. 21(6). 847–855. 1 indexed citations

15.

Gropler, Robert J., Edward M. Geltman, Kondapuram S. Sampathkumaran, et al.. (1992). Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. Journal of the American College of Cardiology. 20(3). 569–577. 95 indexed citations

16.

Moerlein, Stephen M. & Joel S. Perlmutter. (1992). Specific binding of to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET. Neuroscience Letters. 148(1-2). 97–100. 7 indexed citations

17.

Lee, K. J., et al.. (1990). Regional variation in myocardial accumulation of 18 F-fluorodeoxyglucose in fasted normal subjects. Journal of the American College of Cardiology. 15(2). A80–A80. 6 indexed citations

18.

Moerlein, Stephen M., et al.. (1990). N-Fluoroalkylated and N-alkylated analogs of the dopaminergic D-2 receptor antagonist raclopride. Journal of Medicinal Chemistry. 33(9). 2430–2437. 20 indexed citations

19.

Moerlein, Stephen M., et al.. (1990). No-carrier-added radiosynthesis of [123I]HIPDM: N,N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-[123I]iodobenzyl)-1,3-propanediamine. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 41(3). 253–257. 3 indexed citations

20.

Moerlein, Stephen M., K.B. Dalal, S Ebbe, Y. Yano, & Thomas F. Budinger. (1988). Residualizing and non-residualizing analogues of low-density lipoprotein as iodine-123 radiopharmaceuticals for imaging LDL catabolism. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 15(2). 141–149. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact